Abstract: The .alpha.,.alpha.-dibromo-substituted or unsubstituted-4-pivaloyl toluenes, e.g., .alpha.,.alpha.-dibromo-4-pivaloyl toluene, are prepared by bromination of a corresponding p-pivaloyl toluene with liquid bromine at a temperature of at least 125.degree. C.
Abstract: Anti-inflammatory agents of the formula: ##STR1## wherein R.degree. is hydrogen, halo, alkoxy, alkyl, or CF.sub.3 or two adjacent R.degree. together may also form methylenedioxy,R is hydrogen or lower alkyl, andn is 1 or 2.
Abstract: Isatoic anhydrides of the formula: ##STR1## wherein R is alkyl, phenyl or phenalkyl and R.sub.1 and R.sub.2 are hydrogen, halo, alkyl, alkoxy or together methylenedioxy are intermediates reactable with an acyclic 5-methyl-thiopseudourea and acetonitrile to pharmaceutical agents, for example, analgetic and hypotensive agents, of the formula: ##STR2## wherein R, R.sub.1 and R.sub.2 are as defined and R.sup.o is hydrogen, alkyl, .omega.-alkenyl or phenyl.
Abstract: This invention provides compounds of the formula, ##STR1## in which R.sub.1 signifies straight or branched chain alkyl in which a single methyl group is replaced by a mono-, di- or tri-halomethyl group; R.sub.2 signifies hydrogen or straight or branched chain lower alkyl and X and Z each independently signifies oxygen or sulphur, which are useful as animal feed additives and amoebicidal agents.
Abstract: Disclosed are optical brightening agents, such agents being 2-(2')-benzimidazoyl-furans substituted in the 5-position of the furan ring by a 1-aryl-pyrazolyl-3, -4 or -5 radical, by a pyrazolyl-1 radical or by a 2-aryl-v-triazolyl-4 radical, such compounds being in free base, acid addition or quaternary ammonium salt form.
Type:
Grant
Filed:
May 19, 1975
Date of Patent:
April 19, 1977
Assignee:
Sandoz Ltd.
Inventors:
Peter Stuart Littlewood, Alec Victor Mercer
Abstract: Inflatable cuff-type catheters, e.g., endotracheal and tracheotomy tubes, with cuff pressure indicators are provided. One indicator means comprises an expandable chamber with an open-ended spring about the mid-section of the chamber. As the chamber expands, the spring also expands to indicate the gas pressure in the cuff.
Abstract: Dyes of the formula ##STR1## wherein D is a carbocyclic aryl or heterocyclic aryl diazo component radical,q is 0 to 3, andt is 0, 1 or 2,With the proviso that q + t is 1 to 5, are highlyThe dyeing, padding and printing of textile fibers and textiles of natural or regenerated cellulose and paper. The dyes build-up well, exhibit good fastness to wet treatments, alcohol, light, rubbing and dry cleaning and are resistant to acids and alkalis.
Abstract: Anti-inflammatory agents of the formula: ##STR1## wherein R is lower alkyl, lower alkenyl, lower alkynyl, benzyl, alkyl or halo-substituted benzyl or cycloalkylalkyl, X is CH or N, R' is hydrogen, halo, lower alkyl or lower alkoxy when X is CH and hydrogen and alkyl when X is N, and R" is hydrogen or lower alkyl.
Abstract: Substituted or unsubstituted oxadiazolyl benzamides, e.g., o-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-methyl-benzamide, are prepared by reacting a corresponding substituted or unsubstituted oxadiazoyl benzoic acid alkyl ester with an amine and are useful as minor tranquilizers and sleep inducers.
Abstract: The present invention concerns a novel process for the reduction of a nitro-anthraquinone compound of formula I: ##STR1## wherein M IS AN INTEGER 1, 2 OR 3, ANDn is an integer 1, 2 or 3,The sum of m + n being 3, 4 or 5, and the rings A and B are either further substituted or unsubstituted,To the corresponding amino-anthraquinone compound which comprises reacting the compound of formula I with hydrazine in aqueous medium. The resulting amino-anthraquinone compounds are in general known and are useful intermediates in the production of anthraquinone dyestuffs.
Abstract: A synergistic insecticidal composition comprises as a first ingredient the .beta.-exotoxin of Bacillus thuringiensis or a metal salt thereof and has a second ingredient of one or more of the following chemical insecticides:O,o-diethyl-O-(2-isopropyl-4-methyl-6-pyrimidyl) thionophosphate,O,o-dimethyl, .alpha.,.alpha.,.alpha.-trichloro-1-hydroxyethyl phosphonate,.alpha.-methoxy-4H-1,3,2-benzodioxaphosphorin-2-thione,O,o,-dimethyl S-(.alpha.-(ethoxycarbonyl)benzyl) phosphorodithioate,O,o-dimethyl S-(4-chlorophenyl) phosphorothioateThe first and second ingredients are used generally in a ratio of about 0.5:1 to 2.0:1 and may be dispersed in a major portion of an agronomically acceptable carrier.
Abstract: Alkanoyl substituted benzoic acids and esters, e.g., p-pivaloyl ethyl benzoate, are prepared by oxidizing alkanoyl substituted toluene and reacting with lower alkanols and are useful as hypolipidemic, anti-obesity, and anti-diabetic agents.
Abstract: The invention discloses 1,2,5,6-tetrahydro-4H-pyrrolo-(3,2,1-ij)quinolin-2-ones having pharmacological activity in animals and useful as CNS depressant agents. The compounds may be prepared by treating a haloacetyl derivative of 1,2,3,4-tetrahydroquinoline with a Friedel-Crafts catalyst. The haloacetyl derivative of 1,2,3,4-tetrahydroquinoline may be prepared by reacting 1,2,3,4-tetrahydroquinoline with a haloacetyl halide at a mole ratio of 2:1 in the presence of an inert, organic solvent.
Abstract: This invention provides compounds of formula I, ##STR1## wherein R.sub.1 is alkyl of 1 to 10 carbon atoms, cycloalkyl of 3 to 8 carbon atoms or phenyl, andR.sub.2 is hydrogen or alkyl of 1 to 4 carbon atoms,Useful as anti-phlogistics, anti-pyretics, analagesics and inhibitors of blood platelet aggregation.
Type:
Grant
Filed:
January 30, 1975
Date of Patent:
March 22, 1977
Assignee:
Sandoz Ltd.
Inventors:
Annemarie Closse, Walter Haefliger, Daniel Hauser
Abstract: Substituted or unsubstituted-3-pyridyl and pyridyl-N-oxide-furo[3,4-e]-as-triazines, e.g., 5,7-dihydro-3-(2-pyridyl)-5,5,7,7-tetramethyl-furo[3,4-e] -as-triazine are prepared by reacting 2,2,5,5-tetramethyl-3,4(2H,5H)furandiones with substituted or unsubstituted pyridylcarboxamidic acid hydrazides and are useful as sleep inducers and minor tranquilizers.
Abstract: Monoazo compounds of the formula ##STR1## in which each of R.sub.1, R.sub.2 and R.sub.3, which may be the same or different, signifies a methyl or ethyl radical, which are useful as disperse dyes for substrates comprising or consisting of synthetic or semi-synthetic hydrophobic high molecular weight polymers, e.g., linear aromatic polyesters, cellulose acetates and synthetic polyamides. The dyeings exhibit notable fastness to light, heat treatments, wet treatments, perspiration, solvents, lubricants, rubbing, cross-dyeing, ozone, flue gas and chlorine and resistance to permanent pressing, soil release finishes and reduction.
Abstract: CNS depressants of the formulae IA and IB: ##STR1## in which n and p are each 0 or 1, Z.sup.- is an anion and R.sub.1, R'.sub.1, R.sub.2, R'.sub.2, R.sub.3 and R.sub.4 are optional substituents. Compounds IB may be prepared by reducing compounds IA which may be made by reacting a N-(.omega.-haloalkyl) isatoic anhydride with a cyclic pseudothiourea such as a 2-organomercapto-4,5-dihydroimidazole. Compounds IB may be also prepared by cyclizing a 1-(.omega.-haloalkyl)-2,3-dihydro-imidazo[2,1-b]quinazolin-1H-5-one. The compounds are anti-inflammatory, analgesic and immunosuppressant agents.
Abstract: This invention provides controlled, e.g., sustained release of drugs from medicament formulations containing a plurality of medicaments, wherein a desirable release pattern is maintained for both low concentration and high concentration drugs of the formulation.
Abstract: This invention provides a purification process for crude 1-nitroanthraquinone which comprises treating the crude 1-nitroanthraquinone with a base or a basic hydrolyzable salt, in the presence of a solvent and at an elevated temperature, and isolating the purified 1-nitroanthraquinone. The process particularly removes substantial proportions of dinitroanthraquinones and oxidation products.